78 related articles for article (PubMed ID: 7478545)
21. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
[TBL] [Abstract][Full Text] [Related]
22. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
Velasco JA; Avila MA; Notario V
Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
[TBL] [Abstract][Full Text] [Related]
23. Activation of the K-ras gene by insertion mutations in chemically induced rat renal mesenchymal tumors.
Higinbotham KG; Rice JM; Buzard GS; Perantoni AO
Oncogene; 1994 Sep; 9(9):2455-9. PubMed ID: 8058308
[TBL] [Abstract][Full Text] [Related]
24. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
25. Oncogene ect2 is related to regulators of small GTP-binding proteins.
Miki T; Smith CL; Long JE; Eva A; Fleming TP
Nature; 1993 Apr; 362(6419):462-5. PubMed ID: 8464478
[TBL] [Abstract][Full Text] [Related]
26. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.
Chan AM; Miki T; Meyers KA; Aaronson SA
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7558-62. PubMed ID: 8052619
[TBL] [Abstract][Full Text] [Related]
27. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning.
Chan AM; Takai S; Yamada K; Miki T
Oncogene; 1996 Mar; 12(6):1259-66. PubMed ID: 8649828
[TBL] [Abstract][Full Text] [Related]
28. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.
Luo RZ; Fang X; Marquez R; Liu SY; Mills GB; Liao WS; Yu Y; Bast RC
Oncogene; 2003 May; 22(19):2897-909. PubMed ID: 12771940
[TBL] [Abstract][Full Text] [Related]
29. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
30. Guanine nucleotide exchange factors: activators of Ras superfamily proteins.
Overbeck AF; Brtva TR; Cox AD; Graham SM; Huff SY; Khosravi-Far R; Quilliam LA; Solski PA; Der CJ
Mol Reprod Dev; 1995 Dec; 42(4):468-76. PubMed ID: 8607978
[TBL] [Abstract][Full Text] [Related]
31. Mutations induced by 1-nitrosopyrene and related compounds during DNA replication in human cells and induction of homologous recombination by these compounds.
Maher VM; Bhattacharyya NP; Mah MC; Boldt J; Yang JL; McCormick JJ
Res Rep Health Eff Inst; 1993 Mar; (55):1-40; discussion 41-51. PubMed ID: 8466678
[TBL] [Abstract][Full Text] [Related]
32. Functional analysis of Ran/TC4 as a protein regulating T-cell costimulation.
Nieland JD; Haks MC; Kremers BL; Leupers TJ; Bakker AQ; Offringa R; Kruisbeek AM
Cancer Gene Ther; 1998; 5(5):259-73. PubMed ID: 9824045
[TBL] [Abstract][Full Text] [Related]
33. ARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancers.
Johnstone CN; Castellví-Bel S; Chang LM; Bessa X; Nakagawa H; Harada H; Sung RK; Piqué JM; Castells A; Rustgi AK
Gene; 2004 Jul; 336(1):59-71. PubMed ID: 15225876
[TBL] [Abstract][Full Text] [Related]
34. Functional interaction of wild-type and mutant p53 transfected into human tumor cell lines carrying activated ras genes.
Sharma S; Schwarte-Waldhoff I; Oberhuber H; Schäfer R
Cell Growth Differ; 1993 Oct; 4(10):861-9. PubMed ID: 8274455
[TBL] [Abstract][Full Text] [Related]
35. SSCP detection of N-ras promoter mutations in AML patients.
Thorn J; Molloy P; Iland H
Exp Hematol; 1995 Sep; 23(10):1098-103. PubMed ID: 7656930
[TBL] [Abstract][Full Text] [Related]
36. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park DJ; Nakamura H; Chumakov AM; Said JW; Miller CW; Chen DL; Koeffler HP
Oncogene; 1994 Jul; 9(7):1899-906. PubMed ID: 8208536
[TBL] [Abstract][Full Text] [Related]
37. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
38. Two adjacent mutations at position 12 activate the K-ras2 oncogene of a human mammary tumor cell line.
Prosperi MT; Even J; Calvo F; Lebeau J; Goubin G
Oncogene Res; 1987 Jul; 1(2):121-8. PubMed ID: 3329712
[TBL] [Abstract][Full Text] [Related]
39. ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential.
Frémin C; Guégan JP; Plutoni C; Mahaffey J; Philips MR; Emery G; Meloche S
Oncogene; 2016 Oct; 35(43):5692-5698. PubMed ID: 27086924
[TBL] [Abstract][Full Text] [Related]
40. Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3.
Ohba Y; Mochizuki N; Yamashita S; Chan AM; Schrader JW; Hattori S; Nagashima K; Matsuda M
J Biol Chem; 2000 Jun; 275(26):20020-6. PubMed ID: 10777492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
